Connect with us
In this final part of a four-part webinar recap, James Graham, Executive Director of Recce Pharmaceuticals (ASX:RCE) presented on the company’s latest announcements and updates, while answering...
In this part three of a four-part webinar recap, Darren Lui, President and Executive Director of Aptorum Group (NASDAQ/EURONEXT:APM) presented on the company’s latest announcements and updates,...
In this part two of a four-part webinar recap, Sean Hall, Chief Executive Officer and Managing Director of Medlab (ASX:MDC) presented on the company’s latest announcements and...
In this one of a four-part webinar recap, Mark Diamond, Managing Director & CEO of Antisense Therapeutics Limited (ASX:ANP) presented on the company’s latest announcements and...
StockPal is hosting its first Biotech & Healthcare webinar on 4 August for four ASX- and NASDAQ-listed health care companies. This webinar is co-organised with Rawson Lewis....
StockPal is hosting its first Biotech & Healthcare webinar for four ASX- and NASDAQ-listed health care companies. Each company is given 15 minutes to present via...
The S&P/ASX 200 Index fell 0.9 percent after recent surge in COVID-19 cases in Victoria area and record-high unemployment rate. The giant miners reversed some of...
The S&P/ASX200 Index retreated 0.6 percent as tech stocks led the slump. ‘Buy now, pay later’ fintech darling Afterpay (ASX:APT) plunged 7.2 percent and banking giant Commonwealth Bank...
The S&P/ASX 200 Index recovered slightly at 0.6 percent today after strong performances from the ‘buy-now, pay-later’ stocks. Payment giant Afterpay (ASX:APT) started the momentum as it surged...
The S&P/ASX 200 Index managed to edge out 0.6 percent gain as it begins its new financial year.Banking stocks helped the cause as National Australia Bank (ASX:NAB) soared...